EP Patent

EP4346878A1 — Treatment and prevention of osteoporosis in high body mass index individuals

Assigned to Radius Health Inc · Expires 2024-04-10 · 2y expired

What this patent protects

Disclosed herein is a method for preventing or reducing bone fractures in an overweight subject. The method comprises administering to the subject a therapeutically effective amount of an osteoanabolic agent.

USPTO Abstract

Disclosed herein is a method for preventing or reducing bone fractures in an overweight subject. The method comprises administering to the subject a therapeutically effective amount of an osteoanabolic agent.

Drugs covered by this patent

Patent Metadata

Patent number
EP4346878A1
Jurisdiction
EP
Classification
—
Expires
2024-04-10
Drug substance claim
No
Drug product claim
No
Assignee
Radius Health Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.